The global ulcerative colitis therapeutics market is valued at USD 7.2 billion in 2025. As per Fact.MR analysis, the industry will grow at a CAGR of 5.1% and will reach USD 11.9 billion by 2035. Ulcerative colitis, a type of chronic inflammatory bowel disease, causes acute inflammation and ulceration in the large bowel and rectum. In 2024, the therapeutics industry for ulcerative...

Ulcerative Colitis (UC), a chronic inflammatory bowel disease characterized by inflammation of the colon and rectum, has significantly impacted the lives of millions worldwide. With its unpredictable nature and potential for severe complications, the quest for effective ulcerative colitis therapeutics has become more crucial than ever. Before delving into the therapeutic landscape, it's...

The global ulcerative colitis therapeutics market is valued at USD 7.2 billion in 2025. As per Fact.MR analysis, the industry will grow at a CAGR of 5.1% and will reach USD 11.9 billion by 2035. Ulcerative colitis, a type of chronic inflammatory bowel disease, causes acute inflammation and ulceration in the large bowel and rectum. In 2024, the therapeutics industry for ulcerative...